Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study

Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel repeatable treatment for peritoneal carcinomatosis. The available evidence from the pioneer center suggests good tolerance and high response rates, but independent confirmation is needed. A single-cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hübner, Martin, Teixeira Farinha, Hugo, Grass, Fabian, Wolfer, Anita, Mathevet, Patrice, Hahnloser, Dieter, Demartines, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346367/
https://www.ncbi.nlm.nih.gov/pubmed/28331493
http://dx.doi.org/10.1155/2017/6852749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346367/
https://www.ncbi.nlm.nih.gov/pubmed/28331493
http://dx.doi.org/10.1155/2017/6852749

Ejemplares similares